Velosbio Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa)

This study tested an experimental drug called VLS-101 (zilovertamab vedotin) in 102 people with advanced solid tumors that had spread and stopped responding to previous treatments. The trial aimed to see if the drug could shrink tumors and was safe for cancers including breast, l…